Whiteley G - Search Results

1

Proteomics in clinical trials and practice: present uses and future promise.

Azad NS, Rasool N, Annunziata CM, Minasian L, Whiteley G, Kohn EC. Azad NS, et al. Among authors: whiteley g. Mol Cell Proteomics. 2006 Oct;5(10):1819-29. doi: 10.1074/mcp.R600008-MCP200. Epub 2006 May 30. Mol Cell Proteomics. 2006. PMID: 16737951 Free article. Review.

2

Ovarian cancer in the proteomics era.

Annunziata CM, Azad N, Dhamoon AS, Whiteley G, Kohn EC. Annunziata CM, et al. Among authors: whiteley g. Int J Gynecol Cancer. 2008 Mar-Apr;18 Suppl 1:1-6. doi: 10.1111/j.1525-1438.2007.01096.x. Int J Gynecol Cancer. 2008. PMID: 18336391 Review.

3

Proteomics as a tool for biomarker discovery.

Kohn EC, Azad N, Annunziata C, Dhamoon AS, Whiteley G. Kohn EC, et al. Among authors: whiteley g. Dis Markers. 2007;23(5-6):411-7. doi: 10.1155/2007/967023. Dis Markers. 2007. PMID: 18057524 Free PMC article. Review.

4

Clinical proteomics and biomarker discovery.

Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, Liotta LA. Johann DJ Jr, et al. Ann N Y Acad Sci. 2004 Jun;1022:295-305. doi: 10.1196/annals.1318.045. Ann N Y Acad Sci. 2004. PMID: 15251975

5

Proteomic patterns for cancer diagnosis--promise and challenges.

Whiteley GR. Whiteley GR. Mol Biosyst. 2006 Aug;2(8):358-63. doi: 10.1039/b607260g. Epub 2006 Jun 30. Mol Biosyst. 2006. PMID: 16880955 Review.

6

Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients.

Johann DJ Jr, McGuigan MD, Tomov S, Fusaro VA, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA. Johann DJ Jr, et al. Dis Markers. 2003-2004;19(4-5):197-207. doi: 10.1155/2004/549372. Dis Markers. 2003. PMID: 15258334 Free PMC article.

7

Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.

Ménard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K. Ménard C, et al. Among authors: whiteley g. Cancer Res. 2006 Feb 1;66(3):1844-50. doi: 10.1158/0008-5472.CAN-05-3466. Cancer Res. 2006. PMID: 16452246

8

Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.

Liu C, Shea N, Rucker S, Harvey L, Russo P, Saul R, Lopez MF, Mikulskis A, Kuzdzal S, Golenko E, Fishman D, Vonderheid E, Booher S, Cowen EW, Hwang ST, Whiteley GR. Liu C, et al. Proteomics. 2007 Nov;7(22):4045-52. doi: 10.1002/pmic.200601044. Proteomics. 2007. PMID: 17952875

9

Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA.

Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Schoenherr RM, et al. Among authors: whiteley gr. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. Mol Cell Proteomics. 2015. PMID: 25512614 Free PMC article.

10

Analytical considerations for mass spectrometry profiling in serum biomarker discovery.

Whiteley GR, Colantonio S, Sacconi A, Saul RG. Whiteley GR, et al. Clin Lab Med. 2009 Mar;29(1):57-69. doi: 10.1016/j.cll.2009.01.003. Clin Lab Med. 2009. PMID: 19389551 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page